Evidence map›Paper›PMID 32169920›Full record

ArticleJournal of nuclear medicine : official publication, Society of Nuclear Medicine2020

Moving Toward Multicenter Therapeutic Trials in Amyotrophic Lateral Sclerosis: Feasibility of Data Pooling Using Different Translocator Protein PET Radioligands.

Donatienne Van Weehaeghe, Suma Babu, Joke De Vocht, Nicole R Zürcher, Sheena Chew, Chieh-En J Tseng, Marco L Loggia, Michel Koole, Ahmadreza Rezaei, Georg Schramm and 4 more

Open access · bronzeAbstract readMulticenter Study
In one paragraph

Article in Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.1field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 32 citations in OpenAlex.

  1. Imaging the interaction of astrocytes and neurons.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2026
    Article
  2. Increased [Biomolecules · 2025
    Article
  3. Microglial Activation Visualized by [European journal of neurology · 2025
    Article
  4. Quantification of FDG in the spinal cord using PET/MRI.Frontiers in nuclear medicine · 2025
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Pharmaceutics · 2022
    Review
  12. Review
  13. A pilot [Brain, behavior, & immunity - health · 2021
    Article
  14. Novel Tracers and Radionuclides in PET Imaging.Radiologic clinics of North America · 2021
    Review
  15. Review
  16. The Use, Standardization, and Interpretation of Brain Imaging Data in Clinical Trials of Neurodegenerative Disorders.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2021
    Review
  17. Review
  18. Review
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 2 countries.

Donatienne Van WeehaegheNuclear Medicine Subdivision, Department of Imaging and Pathology, University Hospital Leuven, Leuven, Belgium donatienne.vanweehaeghe@uzleuven.be.
Suma BabuDepartment of Neurology, Sean M. Healey and AMG Center for ALS, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
Joke De VochtDepartment of Neurology, University Hospital Leuven, and Laboratory of Neurobiology, Center for Brain and Disease Research, VIB, Leuven, Belgium; and.
Nicole R ZürcherAthinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Harvard Medical School, Charlestown, Massachusetts.
Sheena ChewDepartment of Neurology, Sean M. Healey and AMG Center for ALS, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
Chieh-En J TsengAthinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Harvard Medical School, Charlestown, Massachusetts.
Marco L LoggiaAthinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Harvard Medical School, Charlestown, Massachusetts.
Michel KooleNuclear Medicine Subdivision, Department of Imaging and Pathology, University Hospital Leuven, Leuven, Belgium.
Ahmadreza RezaeiNuclear Medicine Subdivision, Department of Imaging and Pathology, University Hospital Leuven, Leuven, Belgium.
Georg SchrammNuclear Medicine Subdivision, Department of Imaging and Pathology, University Hospital Leuven, Leuven, Belgium.
Philip Van DammeDepartment of Neurology, University Hospital Leuven, and Laboratory of Neurobiology, Center for Brain and Disease Research, VIB, Leuven, Belgium; and.
Jacob M HookerAthinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Harvard Medical School, Charlestown, Massachusetts.
Koen Van LaereNuclear Medicine Subdivision, Department of Imaging and Pathology, University Hospital Leuven, Leuven, Belgium.
Nazem AtassiDepartment of Neurology, Sean M. Healey and AMG Center for ALS, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
KU Leuven · BEMassachusetts General Hospital · USAthinoula A. Martinos Center for Biomedical Imaging · USVIB-KU Leuven Center for Brain & Disease Research · BEHarvard University · US

Funding

Molecular Imaging of Inflammation in Amyotrophic Lateral Sclerosis (ALS)K23NS083715 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI ATASSI, NAZEM · 2014 to 2018
$927k
Carbon-11 Automation Equipment for Human PET Radiotracer ProductionS10OD023517 · OD · MASSACHUSETTS GENERAL HOSPITAL · PI HOOKER, JACOB M. · 2018 to 2018
$502k
NIH HHS S10 OD023517NINDS NIH HHS K23 NS083715
6 · The paper itself

Abstract

Neuroinflammation has been implicated in amyotrophic lateral sclerosis (ALS) and can be visualized using translocator protein (TSPO) radioligands. To become a reliable pharmacodynamic biomarker for ALS multicenter trials, TSPO radioligands have some challenges to overcome. We aimed to investigate whether multicenter data pooling of different TSPO tracers (

Indexed as

AcetamidesAdultAgedAmyotrophic Lateral SclerosisCarbon RadioisotopesClinical Trials as TopicFeasibility StudiesFemaleFluorine RadioisotopesHumansMaleMiddle AgedPositron-Emission TomographyPyrazolesPyridinesPyrimidinesAcetamidesCarbon RadioisotopesFluorine RadioisotopesN-(2-methoxybenzyl)-N-(4-phenoxypyridin-3-yl)acetamideN,N-diethyl-2-(2-(4-(2-fluoroethoxy)phenyl)-5,7-dimethylpyrazolo(1,5-a)pyrimidin-3-yl)acetamidePyrazolesPyridinesPyrimidinesReceptors, GABATSPO protein, human11C-PBR2818F-DPA714amyotrophic lateral sclerosismulticentertranslocator protein

Identifiers

PMID32169920
PMCPMC9364895
OpenAlexW3012033764

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.